IMM 1.47% 33.5¢ immutep limited

prima biomed to release interim cvac clinical , page-27

  1. 701 Posts.
    Well, it's the only approved cancer immunotherapy, but it's not who we should be comparing PRR too.

    NWBO (dendritic GMB vaccine) has gone up around 100% in the last couple of days, most likely based on an announcement regarding the manufacturing approval in Germany at the Fraunhofer Institute.

    Sound familiar? Yes, the same institute that manufactures CVac gave Prima a grant.

    http://www.izi.fraunhofer.de/zelltechnik-gmp-projekte.html?&L=1&print=1

    There are other interesting players researching immunotherapy, and while all quite different to each other and Cvac, I find it more useful to compare Prima to them than DNDN.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.005(1.47%)
Mkt cap ! $493.8M
Open High Low Value Volume
34.0¢ 34.0¢ 33.5¢ $77.86K 230.5K

Buyers (Bids)

No. Vol. Price($)
10 131346 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 69657 6
View Market Depth
Last trade - 10.28am 30/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.